Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | 0.11% | 82.36 | 0.7% | $1556.69m | |
| JNJ | Johnson & Johnson | -0.04% | 165.70 | 0.7% | $1044.17m | |
| PFE | Pfizer Inc. | 0.37% | 43.70 | 0.9% | $945.42m | |
| ABBV | AbbVie, Inc. | -0.08% | 109.32 | 1.9% | $659.34m | |
| LLY | Eli Lilly & Co. | 0.43% | 249.55 | 1.1% | $641.87m | |
| BMY | Bristol-Myers Squibb Co. | -0.16% | 58.12 | 1.0% | $633.95m | |
| AZN | AstraZeneca Plc | 0.11% | 62.33 | 1.0% | $285.30m | |
| NVS | Novartis AG | -1.85% | 83.26 | 0.2% | $179.31m | |
| GSK | GlaxoSmithKline Plc | -0.92% | 39.79 | 0.2% | $163.74m | |
| AVIR | Atea Pharmaceuticals, Inc. | 0.00% | 12.39 | 0.3% | $123.47m | |
| RGEN | Repligen Corp. | 0.00% | 273.83 | 6.8% | $109.24m | |
| VTRS | Viatris, Inc. | 0.30% | 13.52 | 0.0% | $89.79m | |
| NVO | Novo Nordisk A/S | -1.31% | 105.97 | 0.1% | $89.66m | |
| SNY | Sanofi | -1.10% | 49.41 | 0.2% | $65.71m | |
| OGN | Organon & Co. | -0.33% | 36.62 | 0.0% | $52.99m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.